Table 3

Results of the physical health dimension of the SF-36v2 in 16 evaluable subjects

Study groups and time points

SF-36v2 scores, mean (SD)


Physical functioning

Role-physical

Bodily pain

General health


Hyal-Joint® (n = 8)

Baseline

31.8 (9.5)

36.1 (9.3)

33.7 (5.5)

48.5 (9.9)

Week 4

34.9 (7.1)

42.2 (7.2)

39.5 (4.5)

46.0 (10.8)

Week 8

34.2 (11.0)

42.8 (6.8)

44.9 (10.1)

51.3 (9.2)

Change baseline vs week 4

3.1 (5.2)

6.1 (3.9)

5.8 (4.7)

-2.5 (8.8)

P value

0.137

0.003

0.011

0.444

Change baseline vs week 8

2.4 (5.2)

6.8 (7.8)

11.1 (9.6)

2.8 (9.7)

P value

0.239

0.045

0.013

0.439

Placebo (n = 8)

Baseline

25.5 (7.5)

41.6 (8.3)

36.4 (4.8)

46.5 (10.4)

Week 4

30.5 (9.7)

41.9 (11.6)

39.5 (5.6)

44.4 (8.4)

Week 8

33.1 (9.0)

44.6 (9.3)

38.6 (5.4)

48.4 (7.9)

Change baseline vs week 4

5.0 (5.1)

0.3 (5.6)

3.2 (3.7)

-2.1 (4.9)

P value

0.028

0.884

0.045

0.267

Change baseline vs week 8

7.6 (5.2)

3.1 (5.0)

2.2 (4.4)

1.9 (5.5)

P value

0.004

0.129

0.199

0.360


Kalman et al. Nutrition Journal 2008 7:3   doi:10.1186/1475-2891-7-3

Open Data